Patrick Lin - 30 Sep 2021 Form 4/A - Amendment Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Business - Strategy Off
Signature
/s/ Patrick Lin by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
30 Sep 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
06 Jan 2022, 15:05:43 UTC
Date Of Original Report
04 Oct 2021
Previous filing
30 Aug 2021
Next filing
04 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Units Award $0 -6,024 -27% $0.000000 16,058 30 Sep 2021 Common Stock 6,024 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death.
F2 This Amendment is being filed to correct the balance in Box 9 - this should have reflected a cumulative balance.